Raise closed, search for fresh raises on Seedstage

Tahoe City, CA

Expanding access to proactive aging treatments through personalized in-home longevity services.

• Innovative Longevity-as-a-Service model: Provides in-home cellular rejuvenation and regenerative therapies tailored to individual aging goals.
• Strong market demand: Positioned in the rapidly growing longevity and regenerative medicine market, projected to reach $63 billion by 2035.
• Proven customer retention: Repeat customers accounted for 47% of revenue between November 2023 and August 2024.
• Scalable business model: Expanding through direct-to-consumer services and white-label partnerships with proactive wellness brands.
• Trackable results: Uses biological age metrics to measure the impact of treatments and empower customers with data-driven aging management.

Elivate is pioneering a proactive approach to aging by providing innovative longevity treatments through its Longevity-as-a-Service model. The company delivers curated in-home experiences, where licensed nurse providers and longevity advisors administer cellular rejuvenation and regeneration therapies designed to slow the aging process and improve healthspan. By integrating personalized treatments with biological age tracking, Elivate empowers individuals to manage their aging proactively rather than reactively. Its concierge model offers convenience, accessibility, and a high level of trust, addressing a growing demand for longevity solutions in a rapidly expanding market.

The funds raised through this offering will be used to scale Elivate’s service offerings, expand its reach through direct-to-consumer and white-label partnerships, and invest in emerging treatments. With a strong foundation of repeat customers, an established product-market fit, and a scalable business model, Elivate is positioned to lead the longevity market. By bridging the gap between cutting-edge aging science and consumer accessibility, the company is creating a new category of preventative health services that align with the increasing demand for proactive aging solutions.

Company Info

Elivate provides in-home, proactive aging treatments through a concierge model that combines cellular rejuvenation therapies with biological age tracking.

Elivate is a longevity-focused health service company that provides in-home, proactive aging treatments designed to track and improve biological age. Through its Longevity-as-a-Service model, Elivate combines cellular rejuvenation and regeneration therapies with personalized concierge care delivered by licensed nurses and longevity advisors. The company integrates advanced health tracking, including biomarker assessments and wearable data, to offer targeted therapies that help clients optimize their healthspan. By curating the latest advancements in longevity science and eliminating barriers to preventative healthcare, Elivate provides a seamless and accessible approach to aging management.

Founded by experienced entrepreneurs with backgrounds in business strategy, healthcare, and wellness, Elivate has established a profitable product-market fit with a repeat customer base contributing to nearly half of its revenue. The company operates with a demand-based, scalable model that minimizes fixed costs while maximizing service efficiency and client engagement. With the longevity and regenerative medicine markets experiencing rapid growth, Elivate aims to expand both its direct-to-consumer offerings and white-label services for wellness brands and digital clinics. The company’s goal is to make cutting-edge aging treatments mainstream and measurable, empowering individuals to take control of their long-term health.